Search for: "Anda Pharmaceuticals, Inc"
Results 41 - 60
of 605
Sort by Relevance
|
Sort by Date
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
21 Oct 2021, 9:50 am
For more details on any of the previous weeks in the New York opioid trial, visit past coverage: New York Opioid Trial Begins With Opening Arguments “Gremlins” Analogy Nets National Headlines New York Agrees to $1.18 Billion Settlement With Three Major Distributors Local Officials, First Responders Testify in New York Opioid Trial New York State Files Motion for Default Judgment Endo Pharmaceuticals Agrees to Settlement Remaining defendants in the trial include Teva… [read post]
20 Sep 2021, 1:23 am
§ 271(e)(2)(C). [2] AbbVie Inc. v. [read post]
16 Sep 2021, 12:57 pm
” The New York State trial is expected to continue into October with remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
20 Aug 2021, 11:30 am
Concordia Pharmaceuticals Inc., S. [read post]
5 Aug 2021, 12:12 pm
(collectively, GSK) sued Teva Pharmaceuticals USA, Inc. in the United States District Court for the District of Delaware for infringement of claims of GSK’s Reissue Patent No. [read post]
7 Apr 2021, 1:20 pm
This Belviq recall has resulted in Belviq lawsuits being filed against the responsible pharmaceutical company, Eisai Inc. [read post]
10 Feb 2021, 7:12 pm
Teva Pharmaceuticals USA, Inc. [read post]
21 Dec 2020, 9:03 pm
Maia Pharmaceuticals, Inc. [read post]
15 Dec 2020, 12:21 pm
Mylan Pharmaceuticals, Inc. [read post]
8 Dec 2020, 1:00 pm
Instead, the ANDA applicants must simply prove that their proposed generic product is bioequivalent of an existing pharmaceutical, often called the innovator drug. [read post]
29 Nov 2020, 9:59 pm
This truism was the basis for the Federal Circuit affirming the District Court's decision against a generic drug producer in its recent decision in Par Pharmaceutical, Inc. v. [read post]
10 Nov 2020, 8:53 pm
Brands LLC of prior Federal Circuit interpretations that venue was coincident with personal jurisdiction, last Thursday the Federal Circuit arrived at a decision regarding where proper venue does not lie in ANDA litigation, in Valeant Pharmaceuticals North America LLC v. [read post]
10 Nov 2020, 2:01 am
Mylan Pharmaceuticals Inc. [read post]
6 Nov 2020, 7:16 am
” On the facts here: Mylan Pharmaceuticals Inc. [read post]
2 Nov 2020, 1:41 pm
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]
8 Oct 2020, 9:59 pm
What Quantum of Culpable Conduct Is Required for an ANDA Applicant to Induce Infringement? [read post]
3 Sep 2020, 9:23 pm
Hikma Pharmaceuticals USA Inc. [read post]
20 Aug 2020, 9:59 pm
Noonan -- ANDA litigation, pursuant to the Hatch-Waxman Act, has become more complicated over the years since enactment of the statute in 1984, with more patents being asserted and more parties participating over the opportunity to market a generic version of a branded, innovator drug. [read post]
13 Aug 2020, 9:59 pm
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
